Business Context and Reporting Period
This Form 8-K reports on the annual meeting of stockholders held by Enochian BioSciences Inc. (trading symbol: ENOB) on July 21, 2023. The filing details the voting results for three proposals submitted to shareholders. Note: The request metadata references "Lunai Bioworks Inc.," but the filing text explicitly identifies the registrant as Enochian BioSciences Inc.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Voting Results
The filing discloses the outcomes of three shareholder proposals:
- Proposal 1: Election of Directors. All seven nominees were elected. While most directors received over 18 million votes in favor, Gregg Alton, James Sapirstein, and Jayne McNicol received significantly higher "Votes Withheld" (ranging from 1.48 million to 1.70 million) compared to the other directors (who received approximately 165,000 to 176,000 withheld votes).
- Proposal 2: Approval of 2023 Equity Incentive Plan. The plan was approved with 18,785,519 votes for, 34,914 votes against, and 8,269 abstentions.
- Proposal 3: Ratification of Auditors. Sadler, Gibb & Associates, LLC was ratified as the independent registered public accounting firm with 20,327,508 votes for, 16,107 votes against, and 13,456 abstentions.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a disclosure of voting results.
Investor Verification Checklist
- Verify the significant number of votes withheld for directors Gregg Alton, James Sapirstein, and Jayne McNicol to understand potential shareholder concerns.
- Confirm the details of the newly approved 2023 Equity Incentive Plan in the company's proxy statement or subsequent filings.
- Review the company's most recent 10-K or 10-Q for financial performance data, as this 8-K does not contain financial metrics.